SEC Form 6-K filed by Quantum Biopharma Ltd.
UNITED STATES
SECURITIES AND EXCHANGECOMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATEISSUER
PURSUANT TO RULE13a-16 OR 15d-16
UNDER THESECURITIES EXCHANGEACT OF 1934
For the month of: November 2024
Commission File Number: 001-39152
| QUANTUM BIOPHARMA LTD. |
| (Translation of registrant's name into English) |
55 University Ave., Suite 1003
Toronto, OntarioM5J2H7, Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
| Quantum BioPharma Ltd. (Registrant) | ||
|
|
|
|
|
| Date: November 25, 2024 | By: | /s/ Donal Carroll | |
|
|
| Donal Carroll, Chief Financial Officer |
|
| 2 |
EXHIBIT INDEX
| Exhibit |
| Description |
|
|
| 3 |